Search results
What Makes Prometheus Biosciences, Inc. (RXDX) a New Buy Stock
Zacks via Yahoo Finance· 2 years agoPrometheus Biosciences, Inc. (RXDX) might move higher on growing optimism about its earnings...
Prometheus Biosciences, Inc. (RXDX) Reports Q4 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 1 year agoPrometheus Biosciences, Inc. (RXDX) delivered earnings and revenue surprises of 1.10% and 6.71%,...
Prometheus Biosciences, Inc. (RXDX) Stock Jumps 69.7%: Will It Continue to Soar?
Zacks via Yahoo Finance· 1 year agoPrometheus Biosciences, Inc. (RXDX) was a big mover last session on higher-than-average trading...
With 67% ownership, Prometheus Biosciences, Inc. (NASDAQ:RXDX) boasts of strong institutional...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Institutions' substantial holdings in Prometheus Biosciences implies that they have...
Prometheus Biosciences (NASDAQ:RXDX) pulls back 15% this week, but still delivers shareholders...
Simply Wall St. via Yahoo Finance· 2 years agoIt's been a soft week for Prometheus Biosciences, Inc. (NASDAQ:RXDX) shares, which are down 15%. But...
Prometheus Biosciences, Inc. (RXDX) is a Great Momentum Stock: Should You Buy?
Zacks via Yahoo Finance· 12 months agoMomentum investing revolves around the idea of following a stock's recent trend in either direction....
Prometheus (RXDX) Stock Surges 70% on Buyout Offer From Merck
Zacks via Yahoo Finance· 1 year agoPrometheus (RXDX) is set to be acquired by Merck for $11 billion, adding Prometheus' lead product...
Wall Street Analysts Think Prometheus Biosciences, Inc. (RXDX) Could Surge 33.49%: Read This Before...
Zacks via Yahoo Finance· 1 year agoThe mean of analysts' price targets for Prometheus Biosciences, Inc. (RXDX) points to a 33.5% upside...
What Makes Prometheus Biosciences (RXDX) an Attractive Investment Choice?
Insider Monkey via Yahoo Finance· 12 months agoBaron Funds, an investment management company, released its “Baron Health Care Fund” first quarter...
Zacks Investment Ideas feature highlights: XBI, Catalyst Pharma, Prometheus Biosciences, Sage...
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – January 16, 2023 – Today, Zacks Investment Ideas feature...